Cooperative Agreement U01DP006929
Award Date 9/30/26
Completion Date 9/29/30
Dollars Obligated $500K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
New York, NY, USA
Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a cooperative agreement totaling $497,921 to The Children's Hospital of Philadelphia on September 30, 2026, under the Centers for Disease Control and Prevention Investigations and Technical Assistance program (CFDA 93.283). The award funds innovations in elucidating the epidemiology of childhood epilepsy using PEDSnet, a national pediatric learning system. Work is performed in Philadelphia,...
- The Centers for Disease Control and Prevention awarded a $418,550 Cooperative Agreement to Massachusetts General Hospital on September 30, 2026, to advance understanding of pediatric epilepsy incidence and risk factors through a multilevel population health approach under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award funds research activity performed at MGH's Research Management Division in Boston, Massachusetts, with a period of performance extending through...
- The Centers for Disease Control and Prevention awarded a $499,995 Cooperative Agreement to Case Western Reserve University on September 30, 2026, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to conduct research on the incidence and risk factors of childhood epilepsy in the United States. Case Western Reserve University's Office of Research Administration, operating in affiliation with University Hospitals of Cleveland, will conduct the research at its Cleveland,...
- The Centers for Disease Control and Prevention awarded National Opinion Research Center a $443,851 cooperative agreement on September 30, 2026, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to conduct epilepsy incidence research among children in the United States. The award funds survey research and data collection activities performed in Chicago, Illinois, over a four-year period ending September 29, 2030. National Opinion Research Center, operating as Norc, is...
- The Centers for Disease Control and Prevention awarded Health Research, Inc. a $389,145 cooperative agreement on June 1, 2026, under CFDA 93.283 (CDC Investigations and Technical Assistance) to strengthen New York State's public health emergency response capacity. The award funds incident management capabilities for early crisis response, community resilience, information management, countermeasures and mitigation, surge management, and biosurveillance. Health Research, Inc. will hire or...
- The Centers for Disease Control and Prevention awarded New York University School of Medicine $246,434 on September 1, 2026, for a project grant investigating epigenetic pathways mediating exposure effects on breast cancer risk in World Trade Center survivors. The award funds research spanning September 1, 2026, through August 31, 2028, and is performed in New York. The project operates under CDC Investigations and Technical Assistance (CFDA 93.283), which supports investigations and...
- The Centers for Disease Control and Prevention awarded a Cooperative Agreement totaling $228,571 to Fund For Public Health In New York, Inc. on September 30, 2026, to prevent foodborne illness in New York City food service settings using informatics tools and advanced data analytics. The award falls under the CDC Investigations and Technical Assistance program (CFDA 93.283), which supports State and local health authorities and other health-related organizations in controlling communicable...
- The Centers for Disease Control and Prevention awarded a $228,571 Cooperative Agreement to Health Research, Inc. on September 30, 2026, under the CDC Investigations and Technical Assistance program (CFDA 93.283) for practice-based research to improve food safety through the Environmental Health Specialists Network (EHS-Net) in New York. The award funds a five-year project period (September 30, 2026 through September 29, 2031) with place of performance in New York. Health Research, Inc., a...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $286,510 Cooperative Agreement under the Blood Disorder Program: Prevention, Surveillance, and Research (CFDA 93.080) to the Center for Public Health Innovation, a woman-owned non-profit organization, for the Sickle Cell Data Collection Program - 2023. This 5-year project, beginning on September 30, 2023, aims to work with state health agencies and other partners to plan, develop, implement, coordinate, and evaluate programs and...
- The Centers for Disease Control and Prevention awarded Esper Biosciences Inc. $614,000 on September 30, 2025, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to develop a rapid point-of-care nucleic acid test for hepatitis C using nanosensors. The award period runs through September 29, 2026, with performance at Esper Biosciences' location in Ithaca, New York. The CDC Investigations and Technical Assistance program supports efforts to control communicable diseases,...